UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Association of Insomnia with Quality of Life, Work Productivity, and Activity Impairment

Quality of life research, 2009-05, Vol.18 (4), p.415-422

2009

Link zum Volltext

Verfügbarkeit prüfen

Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa: Estimates Based on DART Trial Results and Costs for Uganda and Kenya

Value in health, 2011-12, Vol.14 (8), p.1048-1054

2011

Link zum Volltext

Verfügbarkeit prüfen

Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women

Health and quality of life outcomes, 2006-07, Vol.4 (1), p.42-42, Article 42

2006

Link zum Volltext

Verfügbarkeit prüfen

Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument

Quality of life research, 2014-03, Vol.23 (2), p.561-570

2014

Link zum Volltext

Verfügbarkeit prüfen

Su1059 Treatment Satisfaction in Clinical Trial (Aviator) Patients Treated With Interferon-Free, Oral DAA Regimens: External Validation of the Hepatitis C Virus (HCV) Treatment Satisfaction (HCVTSAT) Instrument

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-977-S-977

2014

Link zum Volltext

Verfügbarkeit prüfen

Psychometric Development and Validation of the Chronic Constipation Treatment Satisfaction Questionnaire (CTSAT-Q)

Value in health, 2009-09, Vol.12 (6), p.1004-1010

2009

Link zum Volltext

Verfügbarkeit prüfen

Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial

Quality of life research, 2014-04, Vol.23 (3), p.877-886

2014

Link zum Volltext

Verfügbarkeit prüfen

Su1057 Patient Reported Outcomes (Pros) in French HCV-Infected Patients Treated With Direct Acting Antivirals (DAAs) ± Ribavirin (RBV): Response and Psychometric Evaluation of the HCV-PRO

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-977-S-977

2014

Link zum Volltext

Verfügbarkeit prüfen

Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in France

Clinics and research in hepatology and gastroenterology, 2015-06, Vol.39 (3), p.307-314

2015

Link zum Volltext

Verfügbarkeit prüfen

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Cost effectiveness and resource allocation, 2011-05, Vol.9 (1), p.5-5

2011

Link zum Volltext

Verfügbarkeit prüfen

Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study

The journal of clinical psychiatry, 2009-08, Vol.70 (8), p.1098

2009

Link zum Volltext

Verfügbarkeit prüfen

All-Cause Health Care Charges among Managed Care Patients with Constipation and Comorbid Irritable Bowel Syndrome

Postgraduate medicine, 2011-05, Vol.123 (3), p.122-132

2011

Link zum Volltext

Verfügbarkeit prüfen

Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States

PharmacoEconomics, 2013-05, Vol.31 (5), p.427-444

2013

Link zum Volltext

Verfügbarkeit prüfen

Costs and absence of HCV-infected employees by disease stage

Journal of medical economics, 2015-09, Vol.18 (9), p.691-703

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age

Journal of medical economics, 2014-04, Vol.17 (4), p.250-258

2014

Link zum Volltext

Verfügbarkeit prüfen

T1029 Development of An Instrument to Assess Treatment Satisfaction in Patients with Chronic Constipation

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-468-A-468

2008

Link zum Volltext

Verfügbarkeit prüfen

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US

Current medical research and opinion, 2009-06, Vol.25 (6), p.1343-1353

2009

Link zum Volltext

Verfügbarkeit prüfen

Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US

Current medical research and opinion, 2008-11, Vol.24 (11), p.3085-3096

2008

Link zum Volltext

Verfügbarkeit prüfen

T1030 Similarities Between Constipation with and Without Irritable Bowel Syndrome in a California Medicaid (Medi-Cal) Population: Costs Trends By Category in the 12 Months After Diagnosis from 1997 to 2002

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-468-A-468

2008

Link zum Volltext

Verfügbarkeit prüfen

Insomnia medication use and the probability of an accidental event in an older adult population

Drug, healthcare and patient safety, 2010-01, Vol.2 (default), p.225-232

2010

Link zum Volltext

Verfügbarkeit prüfen

Healthcare Costs and Clinical Sequelae Associated with Constipation in a Managed Care Population: 852

The American journal of gastroenterology, 2007-09, Vol.102, p.S432

2007

Link zum Volltext

Verfügbarkeit prüfen

Cost of Illness for Constipation: Medical, Pharmacy, and Work Absence Costs in Employees with or without Constipation

The American journal of gastroenterology, 2006-09, Vol.101, p.S408

2006

Link zum Volltext

Verfügbarkeit prüfen

The Prevalence and Costs To Treat GI Comorbidities in Persons with Constipation: 1037

The American journal of gastroenterology, 2006-09, Vol.101, p.S407-S408

2006

Link zum Volltext

Verfügbarkeit prüfen

Healthcare Cost Comparisons by Point of Service for Persons with or without Constipation: 1039

The American journal of gastroenterology, 2006-09, Vol.101, p.S408

2006

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Work Absences Associated with Constipation: 1040

The American journal of gastroenterology, 2006-09, Vol.101, p.S409

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Englisch
(103)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association of Insomnia with Quality of Life, Work Productivity, and Activity Impairment

Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa: Estimates Based on DART Trial Results and Costs for Uganda and Kenya

Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women

Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument

Su1059 Treatment Satisfaction in Clinical Trial (Aviator) Patients Treated With Interferon-Free, Oral DAA Regimens: External Validation of the Hepatitis C Virus (HCV) Treatment Satisfaction (HCVTSAT) Instrument

Psychometric Development and Validation of the Chronic Constipation Treatment Satisfaction Questionnaire (CTSAT-Q)

Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial

Su1057 Patient Reported Outcomes (Pros) in French HCV-Infected Patients Treated With Direct Acting Antivirals (DAAs) ± Ribavirin (RBV): Response and Psychometric Evaluation of the HCV-PRO

Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in France

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study

All-Cause Health Care Charges among Managed Care Patients with Constipation and Comorbid Irritable Bowel Syndrome

Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States

Costs and absence of HCV-infected employees by disease stage

Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age

T1029 Development of An Instrument to Assess Treatment Satisfaction in Patients with Chronic Constipation

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US

Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US

T1030 Similarities Between Constipation with and Without Irritable Bowel Syndrome in a California Medicaid (Medi-Cal) Population: Costs Trends By Category in the 12 Months After Diagnosis from 1997 to 2002

Insomnia medication use and the probability of an accidental event in an older adult population

Healthcare Costs and Clinical Sequelae Associated with Constipation in a Managed Care Population: 852

Cost of Illness for Constipation: Medical, Pharmacy, and Work Absence Costs in Employees with or without Constipation

The Prevalence and Costs To Treat GI Comorbidities in Persons with Constipation: 1037

Healthcare Cost Comparisons by Point of Service for Persons with or without Constipation: 1039

Assessment of Work Absences Associated with Constipation: 1040

Suchergebnisse filtern